These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8499854)

  • 1. Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance?
    Davies HA; Lennard L; Lilleyman JS
    BMJ; 1993 May; 306(6887):1239-40. PubMed ID: 8499854
    [No Abstract]   [Full Text] [Related]  

  • 2. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.
    Lilleyman JS; Lennard L
    Lancet; 1994 May; 343(8907):1188-90. PubMed ID: 7909868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.
    Lennard L; Gibson BE; Nicole T; Lilleyman JS
    Arch Dis Child; 1993 Nov; 69(5):577-9. PubMed ID: 8257179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.
    Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM
    Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
    Lilleyman JS; Lennard L; Rees CA; Morgan G; Maddocks JL
    Br J Cancer; 1984 Jun; 49(6):703-7. PubMed ID: 6587901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of non-compliance in lymphoblastic leukaemia.
    Lancaster D; Lennard L; Lilleyman JS
    Arch Dis Child; 1997 Apr; 76(4):365-6. PubMed ID: 9166035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia.
    Rees CA; Lennard L; Lilleyman JS; Maddocks JL
    Cancer Chemother Pharmacol; 1984; 12(2):87-9. PubMed ID: 6607783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?
    Lennard L; Welch J; Lilleyman JS
    Br J Cancer; 1995 Oct; 72(4):1004-6. PubMed ID: 7547211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose.
    Welch J; Lennard L; Morton GC; Lilleyman JS
    Ther Drug Monit; 1997 Aug; 19(4):382-5. PubMed ID: 9263376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.
    Herber S; Lennard L; Lilleyman JS; Maddocks J
    Br J Cancer; 1982 Jul; 46(1):138-41. PubMed ID: 6954968
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
    Brackett J; Schafer ES; Leung DH; Bernhardt MB
    Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mercaptopurine vs thioguanine for the treatment of acute lymphoblastic leukemia.
    Evans WE; Relling MV
    Leuk Res; 1994 Nov; 18(11):811-4. PubMed ID: 7967707
    [No Abstract]   [Full Text] [Related]  

  • 13. Are children with lymphoblastic leukaemia given enough 6-mercaptopurine?
    Lennard L; Lilleyman JS
    Lancet; 1987 Oct; 2(8562):785-7. PubMed ID: 2888996
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia.
    Schmiegelow K; Bruunshuus I
    Cancer Chemother Pharmacol; 1990; 26(4):288-92. PubMed ID: 2369793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.
    Hale JP; Lilleyman JS
    Arch Dis Child; 1991 Apr; 66(4):462-6. PubMed ID: 2031601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells.
    Lennard L; Maddocks JL
    J Pharm Pharmacol; 1983 Jan; 35(1):15-8. PubMed ID: 6131958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia.
    Innocenti F; Danesi R; Favre C; Nardi M; Menconi MC; Di Paolo A; Bocci G; Fogli S; Barbara C; Barachini S; Casazza G; Macchia P; Del Tacca M
    Ther Drug Monit; 2000 Aug; 22(4):375-82. PubMed ID: 10942174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
    Schmiegelow K; Schrøder H; Gustafsson G; Kristinsson J; Glomstein A; Salmi T; Wranne L
    J Clin Oncol; 1995 Feb; 13(2):345-51. PubMed ID: 7531219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trial.
    Hanff LM; Mathot RA; Smeets O; Postma DJ; Ramnarain S; Vermes A; Pieters R; Zwaan CM
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):653-62. PubMed ID: 24800919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.
    Erb N; Harms DO; Janka-Schaub G
    Cancer Chemother Pharmacol; 1998; 42(4):266-72. PubMed ID: 9744770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.